A solar lentigo is a small, well-circumscribed, pigmented macule surrounded by normal-appearing skin. Histopathlogic findings may show epidermal hyperplasia and increased melanin pigmentation of the basal layer. A variable number of melanocytes are present; these melanocytes may be increased in number, but they do not form nests. In the most cases, treatment is not necessary for solar lentigo. However treating the solar lentigo without postinflammatory hyperpigmentation is very difficult and treatment for solar lentigo without side effects such as postinflammatory hyperpigmentation, scars and recurrences cannot be found in any literature yet. Therefore the authors introduce the new treatment of solar lentigo using optimal melanocytic suicide-2 parameter with a high fluence 1064nm Q-switched Nd:YAG laser without side effects or recurrences.
Comments: 5 Pages.
[v1] 2017-08-23 06:09:12
Unique-IP document downloads: 51 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.